With more people taking the weight-loss drugs Wegovy and Zepbound, one question inevitably ... In March, the U.S. Food and Drug Administration allowed the company to add on Wegovy's label that ...
The Food and Drug Administration approved Eli Lilly's blockbuster weight loss drug Zepbound for treating patients with the most common sleep-related breathing disorder. The weekly injection ...
Zepbound, the new GLP-1 weight-loss drug from Eli Lilly & Co., has outperformed its main competitor, Wegovy, in a clinical trial funded by Lilly. "Given the increased interest around obesity ...